Johanna Mercier - May 17, 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
May 17, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 05:16 PM
Previous filing
Mar 13, 2023
Next filing
Jun 12, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Non-Qualified Stock Option Award $0 +4.29K $0.00 4.29K May 17, 2023 Common Stock 4.29K $95.27 Direct F1
transaction NBIX Restricted Stock Unit Award $0 +2.1K $0.00 2.1K May 17, 2023 Common Stock 2.1K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in 12 monthly installments beginning June 17, 2023.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F3 The Restricted Stock Units will vest in full on May 17, 2024.